EP-1249: LH-RH analogue vs antiandrogen plus adjuvant RT in high risk prostate cancer: a ìpooled analysisî.

Saved in:
Bibliographic Details
Title: EP-1249: LH-RH analogue vs antiandrogen plus adjuvant RT in high risk prostate cancer: a ìpooled analysisî.
Authors: Mascia, I.V., Monari, F., Massaccesi, M., Picardi, V., Frascino, V., Macchia, G., Cammelli, S., Deodato, F., Valentini, V., Morganti, A.G.
Source: Radiotherapy & Oncology. 2014 Supplement, Vol. 115, pS675-S676. 1p.
Subjects: Prostate cancer treatment, Antiandrogens, Adjuvant treatment of cancer, Prostate cancer risk factors, Medical research
Database: Engineering Source
Description
ISSN:01678140
DOI:10.1016/S0167-8140(15)41241-1